NovoCure Limited (NVCR)

Last Closing Price: 10.69 (2026-11-19)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

NovoCure Limited (NVCR) had Earnings per Share (EPS) (Diluted) of $-0.09 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$193.40M
$-10.44M
$44.53M
$148.87M
$199.57M
$-6.17M
$-1.71M
$-7.88M
$-7.88M
$-10.44M
$-10.44M
$-10.44M
$-10.44M
$-6.17M
$-4.36M
116.78M
116.78M
$-0.09
Earnings per Share (EPS) (Diluted)
$-0.09
Balance Sheet Financials
$673.52M
$101.03M
$155.19M
$828.71M
$270.66M
$171.34M
$207.44M
$478.10M
$350.61M
$350.61M
$350.61M
116.91M
Cash Flow Statement Financials
$17.28M
$-21.87M
$8.03M
$103.39M
$106.84M
$3.45M
$97.50M
--
--
Fundamental Metrics & Ratios
2.49
--
--
0.33
0.56
76.98%
-3.19%
-3.19%
--
-4.07%
-5.40%
$-1.71M
--
--
--
0.23
1.10
1.21
74.15
-2.98%
-2.98%
-1.26%
-2.00%
$3.00
$-0.01
$0.15